Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Seth A. Townsend"'
Autor:
Robert H. Brown, Robert Langer, Martin Michael Peter Schulz, Gilad D. Evrony, Frank X. Gu, Seth A. Townsend
Publikováno v:
Biomaterials. 28:5176-5184
The use of nanoparticles for targeted drug delivery is often facilitated by specific conjugation of functional targeting molecules to the nanoparticle surface. We compared different biotin-binding proteins (avidin, streptavidin, or neutravidin) as cr
Autor:
Lino Ferreira, Jason A. Burdick, Sharon Gerecht, Robert Langer, Seth A. Townsend, Gordana Vunjak-Novakovic
Publikováno v:
Proceedings of the National Academy of Sciences. 104:11298-11303
Control of self-renewal and differentiation of human ES cells (hESCs) remains a challenge. This is largely due to the use of culture systems that involve poorly defined animal products and do not mimic the normal developmental milieu. Routine protoco
Autor:
Shakil A. Khan, Christoper A. Lemmon, Susanna Cotecchia, Albert S. Jung, Lili A. Barouch, Artin A. Shoukas, Yen Shi Gillian Hoe, Kwangh Ho Lee, Daniel Nyhan, Rafael Y. Lefkowitz, Dan E. Berkowitz, Joshua M. Hare, Robert W. Harrison, Seth A. Townsend
Publikováno v:
Hypertension. 44:776-782
The α-1 adrenergic receptors (α 1 ARs) are critical in sympathetically mediated vasoconstriction. The specific role of each α 1 AR subtype in regulating vasoconstriction remains highly controversial. Limited pharmacological studies suggest that di
Autor:
Christiaan Nijst, Sharon Gerecht, Seth A. Townsend, Jason W. Nichol, Joost P. Bruggeman, Robert Langer, Heather M Pressler, Han Zhu
Publikováno v:
Biomaterials. 28(32)
Encapsulating cells within a polymer matrix creates a three-dimensional (3D) scaffold that may more accurately represent the native microenvironment and cell organization. Here we report a porous scaffold prepared from a photocurable elastomer, poly(
Publikováno v:
Nature Reviews Drug Discovery. 11:513-514
This analysis of the outcomes of advisory committee meetings held by the US Food and Drug Administration (FDA) over the past decade investigates issues such as the consistency between advisory committee votes and FDA approval decisions.